4001ÀϰٻãÍøÕ¾

¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐĺÏ×÷Ñо¿ÅжÏÇàÉÙÄêÔç·¢ÐÔÍ´·çÐÂΣº¦»ùÒòλµã

Í´·çÊÇÓÉѪÇåÄòËáÉý¸ßÒýÆðµÄ´úлÐÔ¼²²¡ £¬¶à±¬·¢ÓÚ³ÉÄêÄÐÐÔ¡£ÔÚÈ«Çò¹æÄ£ÄÚ»¼²¡Âʼ±¾çÔöÌíÇÒ·ºÆðÏÔ×ÅÄêÇữÇ÷ÊÆ £¬²¢ÔÚÊàŦ»ûÐΡ¢¸ÎÉö¹¦Ð§ÊÜËð¼°Òý·¢ÐÄѪ¹Ü¼²²¡µÈ·½ÃæÁÙÇàÉÙÄ꿵½¡Ôì³ÉÁËÑÏÖØÍþв¡£ÏÖÔÚÕë¶ÔÇàÉÙÄêÍ´·ç£¨·¢²¡ÄêËê¡Ü19Ë꣩ÒÅ´«»úÖÆ¼°Ö²¡»úÀíµÄÑо¿½ÏÉÙ £¬ÏÖÒѳÉΪÇàÉÙÄêÍ´·ç·ÀÖÎµÄÆ¿¾±¡£¹ÊÕë¶ÔÇàÉÙÄêÍ´Ê¢ÐÐÁеÄÒÅ´«Ñо¿²»µ«ÄÜΪʹ·çµÄ»úÖÆÌṩеĿ´·¨ £¬Ò²ÄÜΪÇàÉÙÄêÍ´·ç»¼ÕßÌṩеÄÖÎÁưеã¡£

8ÔÂ8ÈÕ £¬¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐÄÆ«Ïò¶«ÍŶӺÍÇൺ´óѧÁ¥ÊôÒ½ÔºÀ¹óÍŶӺÏ×÷ £¬ÔÚArthritis & Rheumatology?ÆÚ¿¯ÔÚÏß½ÒÏþÁËÌâΪ¡°Novel genetic loci in early-onset gout derived from whole genome sequencing of an adolescent gout cohort¡±µÄÑо¿ÂÛÎÄ £¬ÖÜÈ«ÐÎòÁËÇàÉÙÄêÍ´·ç»¼Õß»ùÒò×éÌØÕ÷²¢È·¶¨ÁËÔç·¢ÐÔÍ´·çµÄÐÂΣº¦Î»µã £¬½«ÓÐÖúÓÚ¸üºÃµØÏàʶÇàÉÙÄ걬·¢ÐÔÍ´·çµÄ·¢²¡»úÖÆ £¬ÎªÎ£º¦Õ¹ÍûºÍ¸ÉÔ¤Ô¤·ÀÇàÉÙÄêÔç·¢ÐÔÍ´·çÌṩÖ÷ÒªÒÀ¾Ý¡£

¸ÃÑо¿¶Ô905ÃûÇàÉÙÄêÍ´·ç·¢Ã÷ÐÐö¾ÙÐÐÁËÈ«»ùÒò×é²âÐò £¬Ãè»æÁËÇàÉÙÄêÍ´·çºÍ¸ßÄòËáѪ֢µÄ»ùÒò×éͼÆ× £¬²¢Í¨¹ýÈ«»ùÒò×鹨ÁªÆÊÎö¡¢ÐòÁÐÄں˹ØÁª²âÊÔºÍȫת¼×鹨ÁªÆÊÎö £¬ÒÔ¼°ÔÚ2834ÀýÔç·¢ÐÔÍ´·çÑéÖ¤ºóµÄÜöÝÍÆÊÎö £¬ÅжϳöÁ½¸öеĻùÒò×ù£¨Pmeta < 5.0¡Á10-8£©£ºRCOR1£¨rs12887440Óërs8009475£©ºÍFSTL5-MIR4454£¨rs35213808£© £¬ÌáÐÑ¿ÉÄÜÓëÔç·¢ÐÔÍ´·çÏà¹Ø¡£

ÓëRCOR1?Ïà¹ØµÄÁ½¸ö×îÏÔÖø¹ØÁªSNVλÓÚRCOR1?µÄÆô¶¯×Ó£¨rs8009475£©ºÍµÚ¶þ¸öÄÚº¬×Ó£¨rs12887440£©¡£ÔÚÍ´·çÏà¹ØÏ¸°ûºÍ×éÖ¯ÖÐ £¬°üÀ¨rs12887440µÄÇøÓò¸»º¬»îÐÔ×éÂѰ×ÐÞÊαê¼Ç£¨H3K4me1ºÍH3K27ac£© £¬ÎªÇ±ÔÚµÄÔöÇ¿×Ó £¬²¢Í¨¹ýÔ¶³ÌȾɫÖʹ¹ÏóÏ໥×÷Óõ÷ÀíÆô¶¯×Ó £¬ÌáÐÑrs12887440£¨AΪΣº¦µÈλ»ùÒò£©¿ÉÄÜÓ°ÏìRCOR1?µÄ±í´ï¡£±¾Ñо¿½øÒ»²½Í¨¹ýRT-qPCRºÍRNA²âÐò £¬ÔÚ32ÃûÇàÉÙÄêÍ´·ç»¼ÕßµÄȫѪÖÐÑéÖ¤ÁËrs12887440-AAЯ´øÕßÖÐRCOR1 mRNAˮƽÏÔןßÓÚ·ÇЯ´øÕßrs12887440-GG £¬Ö¤Êµrs12887440ÓëRCOR1?µÄ±í´ïÓйØ¡£¶ørs12887440-AAÓërs12887440-GGЯ´øÕßÖ®¼äµÄ²î±ð±í´ï»ùÒò¼ÓÈëÃâÒßϵͳÀú³Ì¡¢ÃâÒß·´Ó¦¡¢Ë³Ó¦ÐÔÃâÒß·´Ó¦¡¢ÃâÒß·´Ó¦µ÷¿ØµÈÃâÒßÏà¹ØÍ¨Â· £¬ÇÒrs12887440ºÍrs8009475ÓëÄòËáˮƽÎÞ¹Ø £¬ÌáÐÑRCOR1?¿ÉÄܼÓÈëÍ´·ç±¬·¢µÄÑ×Ö¢Àú³Ì¡£Í¨¹ýTHP-1¾ÞÊÉϸ°ûÇóýʵÑéÑéÖ¤·¢Ã÷ £¬Ì»Â¶ÓÚÄòËáÑξ§Ìå´Ì¼¤ÃâÒß·´Ó¦ºó £¬RCOR1?ÇõÍϸ°ûÖÐϸ°ûÄÚIL-1¦ÂǰÌåÂѰ×ˮƽºÍÉÏÇåÒºÖÐIL-1¦ÂÂѰ×ˮƽÏÔÖø½µµÍ £¬Åú×¢RCOR1?¿ÉÄÜÆð¾¢¼ÓÈëÍ´·çÑ×Ö¢µÄÉú³¤ £¬¶ÔÄòËáÑξ§ÌåÑ×Ö¢·´Ó¦µÄ¸ü´óÃô¸ÐÐÔ¿ÉÄÜÊÇÔçÆÚ±¬·¢Í´·çµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ¡£

±ðµÄ £¬Ñо¿ÍŶÓÕýÔÚÒ»Á¬¹¹½¨ÖйúÍ´Ê¢ÐÐÁÐ £¬ÔöÌíÐÐÁÐÊýÄ¿ÓëÐÐÁÐÊý¾ÝÖÖÀà £¬²¢ÜöÝͶàÖÖ×éѧÊý¾Ý½¨ÉèÍ´·ç¶à×éѧÊý¾Ý¿â¡£³ä·ÖʹÓÃÍ´Ê¢ÐÐÁÐÓëÊý¾Ý¿â½¨Éè £¬ÔÚÒÑÓÐÑо¿»ù´¡ÉÏʹÓÃÍ´·çSNV¾ÙÐÐÍ´·ç·ÖÐÍ £¬»òÔÚÍ´·çΣº¦ÆÀ·ÖµÄ»ù´¡ÉÏʹÓÃSNVÍŽáÁÙ´²±íÐÍ £¬²¢½øÒ»²½ÍŽá¶à×éѧÌáÉýÍ´·ç·ÖÐÍ׼ȷÂÊ £¬½¨ÉèÊÊÓÃÓÚÑÇÖÞÈ˵ÄΣº¦ÆÀ·ÖÄ£×Ó £¬¶ÔÍ´·ç¾ÙÐÐÁÙ´²Ö¸µ¼ £¬ÌáÉýΣº¦Õ¹ÍûÄÜÁ¦¡£¸ÃÑо¿ÏµÍ³²»µ«Ôö½øÁËҽѧÑо¿ÓëÁÙ´²Êµ¼ùµÄÉî¶ÈÈÚºÏ £¬»¹¶ÔÌáÉýÂýÐÔÖØ´ó¼²²¡µÄ·ÀÖÎˮƽ¡¢¸ÄÉÆ»¼ÕßÉúÑÄÖÊÁ¿¾ßÓÐÖ÷ÒªÒâÒå¡£

Çൺ´óѧÁ¥ÊôÒ½Ôº¼¾°®²ý²©Ê¿¡¢¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐÄËåÑô²©Ê¿¡¢Çൺ´óѧÁ¥ÊôҽԺѦÏþ÷¡¢¼ÍÏþÅó¡¢¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐÄʱÎÄ©Ê¿¡¢ÉϺ£½»Í¨´óѧBIO-XÑо¿ÔºÊ¦Ó½ÓÂÑо¿Ô±Îª±¾ÎĵÄÅäºÏµÚÒ»×÷Õß £¬Çൺ´óѧÁ¥ÊôÒ½ÔºÀ¹óÖ÷ÈÎҽʦ¡¢¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐÄÆ«Ïò¶«Ñо¿Ô±¡¢ÇþºèÖñ¸±Ñо¿Ô±¡¢ÒÔ¼°ÃÀ¹ú°¢À­°ÍÂí´óѧTony R. Merriman½ÌÊÚΪ±¾ÎÄÅäºÏͨѶ×÷Õß¡£¸ÃÑо¿»ñµÃÁ˹ú¼ÒÖØµãÑз¢ÍýÏë¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðµÈÏîÄ¿×ÊÖú¡£

4001Àϰٻãnet(¼¯ÍÅ)NO.1¹Ù·½ÍøÕ¾

ÇàÉÙÄêÔç·¢ÐÔÍ´·çÐÂΣº¦»ùÒòÅжϼ°¹¦Ð§Ñо¿

ÂÛÎÄÁ´½Ó


¸½¼þÏÂÔØ£º
ÍøÕ¾µØÍ¼